SCHEMBL9505980

SCHEMBL9505980

CN(C)CCN1C(=O)C(O)C(c2ccc(Cl)cc2)Sc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1S Q13698 6/20 0.60
CYP3A4 P08684 4/20 0.57
LMNA P02545 4/20 0.57
TSHR P16473 4/20 0.57
KCNH2 Q12809 4/20 0.57
CACNA1C Q13936 4/20 0.57
ABCB11 O95342 3/20 0.57
SLC22A1 O15245 3/20 0.57
HRH2 P25021 3/20 0.57
ADRA1A P35348 3/20 0.57
SCN1A P35498 3/20 0.57
SCN2A Q99250 3/20 0.57
SCN3A Q9NY46 3/20 0.57
CACNA1F O60840 2/20 0.57
ABCB1 P08183 2/20 0.57
SCN4A P35499 2/20 0.57
SCN7A Q01118 2/20 0.57
CACNA1D Q01668 2/20 0.57
SCN5A Q14524 2/20 0.57
SCN9A Q15858 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10538420 1.00 CACNA1S (0.60) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL9506823 0.91 CACNA1S (0.62) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL11001652 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL1938855 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL9503788 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL12557671 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL10541270 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL5812395 0.90 CACNA1S (0.61) CACNA1SCYP3A4LMNATSHRKCNH2
Hydrochloric Acid SCHEMBL9506837 0.88 ITGB2 (0.48) CACNA1SCYP3A4LMNATSHRKCNH2
SCHEMBL7348976 0.87 CACNA1S (0.79) CACNA1SCYP3A4LMNATSHRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279425-B1 USE OF BENZOTHIAZEPINE DERIVATIVES, IN PARTICULAR DILTIAZEM, IN THE MANUFACTURE OF MEDICAMENTS TO PROTECT LYMPHOCYTES GÖDECKE AKTIENGESELLSCHAFT (DE) 1993-08-04 EP disclosed
US-4861770-A Use of benzothiazepine derivatives as lymphocyte protectors GOEDECKE AKTIENGESELLSCHAFT (DE) 1989-08-29 US disclosed
EP-0279425-A2 Use of benzothiazepine derivatives, in particular diltiazem, in the manufacture of medicaments to protect lymphocytes GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-08-24 EP disclosed